Replies to post #3005 on Halozyme Therapeutics Inc (HALO)

[Fred Kadiddlehopper]

Yes, that'sit. I've said it before and I'll say it again:
F#@K Baxter. Halo's ties with them of them, whatever is left, count as our rookie mistake. It was tuition for the school of hard knocks that will not have been wasted.
Good luck!
-Fritz

[Skeetz99]

HyQvia ramp up will take time...just like Herceptin and MabThera. Baxter has a huge commitment to see HyQvia through and contribute nicely in 2015. The Goldman Sachs analyst was focused on what will contribute in 2014 and I wouldnt disagree that HyQvia will have limited contributions in the 2nd half.